Search Menu
Photonics Media Photonics Marketplace Photonics Spectra BioPhotonics Vision Spectra Photonics Showcase Photonics ProdSpec Photonics Handbook

FDA Approves Optiguide Flexible Fiber

Facebook Twitter LinkedIn Email
Pinnacle Biologics was granted U.S. Food and Drug Administration premarket supplemental approval for its Optiguide DCYL700 Fiber Optic Diffuser Series flexible fiber.

Courtesy of Concordia Healthcare Corp.

Used in the treatment of non-small-cell lung and esophageal cancer, the device features a flexible, narrow cylindrical diffuser design that may give physicians greater access to tumors in the right upper lobe of the lung. It also improves maneuverability in other potentially challenging anatomic areas of the bronchus.

In January, the company reached an agreement with the FDA under a special protocol assessment to enroll patients with an advanced form of bile-duct cancer in a pivotal Phase 3 clinical trial, a cancer type for which there is currently no approved therapy.

Aug 2014
Biophotonicsfiber opticsRapidScan

back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2023 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA, [email protected]

Photonics Media, Laurin Publishing
x Subscribe to BioPhotonics magazine - FREE!
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.